Members |
associationTargetComponent |
peginterferon alfa-2b 120 microgram injection [4 x 120 microgram cartridges] (&) ribavirin 200 mg capsule [140 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack |
peginterferon alfa-2b 120 microgram injection [4 cartridges] (&) ribavirin 200 mg capsule [84] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack |
peginterferon alfa-2b 120 microgram injection [4 x 120 microgram cartridges] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices |
peginterferon alfa-2b 150 microgram injection [4 x 150 microgram cartridges] (&) ribavirin 200 mg capsule [140 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack |
peginterferon alfa-2b 150 microgram injection [4 x 150 microgram cartridges] (&) ribavirin 200 mg capsule [168 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [168], 1 pack |
peginterferon alfa-2b 150 microgram injection [4 x 150 microgram cartridges] (&) ribavirin 200 mg capsule [196 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [196], 1 pack |
peginterferon alfa-2b 150 microgram injection [4 cartridges] (&) ribavirin 200 mg capsule [84] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack |
peginterferon alfa-2b 150 microgram injection [4 x 150 microgram cartridges] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices |
peginterferon alfa-2b 50 microgram injection [4 x 50 microgram cartridges] (&) ribavirin 200 mg capsule [112 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [112], 1 pack |
peginterferon alfa-2b 50 microgram injection [4 cartridges] (&) ribavirin 200 mg capsule [84] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack |
peginterferon alfa-2b 50 microgram injection [4 x 50 microgram cartridges] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices |
peginterferon alfa-2b 80 microgram injection [4 x 80 microgram cartridges] (&) ribavirin 200 mg capsule [140 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack |
peginterferon alfa-2b 80 microgram injection [4 cartridges] (&) ribavirin 200 mg capsule [168] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [168], 1 pack |
peginterferon alfa-2b 80 microgram injection [4 x 80 microgram cartridges] (&) ribavirin 200 mg capsule [84 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack |
peginterferon alfa-2b 80 microgram injection [4 x 80 microgram cartridges] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack |
peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices |
parecoxib 40 mg injection [5 vials] (&) inert substance diluent [5 ampoules], 1 pack |
parecoxib 40 mg injection [5 vials] (&) inert substance diluent [5 x 2 mL ampoules], 1 pack |
meningococcal group C conjugate vaccine 10 microgram injection [5 vials] (&) inert substance diluent [5 x 0.5 mL syringes], 1 pack |
meningococcal C conjugate vaccine injection [5 vials] (&) inert substance diluent [5 x 0.5 mL syringes], 1 pack |
rabies inactivated vaccine 2.5 units injection [5 vials] (&) inert substance diluent [5 x 1 mL ampoules], 1 pack |
rabies vaccine injection [5 vials] (&) inert substance diluent [5 x 1 mL ampoules], 1 pack |
somatropin 12 mg injection [5 cartridges] (&) inert substance diluent [5 x 1 mL cartridges], 1 pack |
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 5 dual chamber pen devices |
somatropin 5 mg injection [5 cartridges] (&) inert substance diluent [5 x 1 mL cartridges], 1 pack |
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 5 dual chamber pen devices |
methylprednisolone 40 mg injection [5 vials] (&) inert substance diluent [5 x 1 mL vials], 1 pack |
methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 x 1 mL chamber], 5 dual chamber vials |
smallpox live vaccine injection [50 vials] (&) inert substance diluent [50 x 0.6 mL vials], 1 pack |
smallpox live vaccine injection [50 vials] (&) inert substance diluent [50 x 0.6 mL vials], 1 pack |
somatropin 1 mg injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 1 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 1.2 mg injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 1.2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 1.4 mg injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 1.6 mg injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 1.8 mg injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 2 mg injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 400 microgram injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 600 microgram injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
somatropin 800 microgram injection [7] (&) inert substance diluent [7 x 0.25 mL syringes], 1 pack |
somatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes |
inert substance diluent, 0.25 mL syringe |
inert substance diluent, 0.25 mL chamber |
inert substance diluent, 0.5 mL cartridge |
inert substance diluent, 0.5 mL chamber |
inert substance diluent, 0.6 mL syringe |
inert substance diluent, 0.5 mL chamber |
inert substance diluent, 1 mL cartridge |
inert substance diluent, 1 mL chamber |
inert substance diluent, 1.1 mL vial |
inert substance diluent, 2 mL vial |
inert substance diluent, 1.5 mL syringe |
inert substance diluent, 1.5 mL chamber |
inert substance diluent, ampoule |
inert substance diluent, 2 mL ampoule |
inert substance powder for oral liquid, 5.6 g sachet |
inert substance effervescent granules, 5.6 g sachet |
nomegestrol acetate 2.5 mg + oestradiol 1.5 mg tablet [72] (&) inert substance tablet [12], 1 pack |
estradiol 1.5 mg + nomegestrol acetate 2.5 mg tablet [24 tablets] (&) inert substance tablet [4 tablets], 3 x 28 tablets (medicinal product pack) |
influenza pandemic inactivated vaccine 2009 |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 15 microgram/0.5 mL injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 15 microgram/0.5 mL injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 15 microgram/0.5 mL injection, syringe |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 150 microgram/5 mL injection, 10 x 5 mL vials |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 150 microgram/5 mL injection, vial |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 300 microgram/10 mL injection, 10 x 10 mL vials |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 300 microgram/10 mL injection, 50 x 10 mL vials |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 300 microgram/10 mL injection, vial |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 7.5 microgram/0.25 mL injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 7.5 microgram/0.25 mL injection, 10 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza pandemic inactivated vaccine 2009 7.5 microgram/0.25 mL injection, syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2015 |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2015 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2015 (adult) injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2015 (child) injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2015 (child) injection, 10 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (adult) injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (adult) injection, 5 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (child) injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (child) injection, 10 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2016 (child) injection, 5 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (adult) injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (adult) injection, 5 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (child) injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (child) injection, 10 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus quadrivalent vaccine 2017 (child) injection, 5 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus trivalent vaccine 2015 |
Unknown Cell Type 2 |
influenza virus trivalent vaccine 2015 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus trivalent vaccine 2015 (adult) injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus trivalent vaccine 2015 (adult) injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus trivalent vaccine 2015 (child) injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus trivalent vaccine 2015 (child) injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2007 |
Unknown Cell Type 2 |
influenza virus vaccine 2007 injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2007 injection, 1 x 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2008 |
Unknown Cell Type 2 |
influenza virus vaccine 2008 injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2008 injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2008 injection, 1 x 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2008 injection, 1 x 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2008 injection, 10 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus vaccine 2008 injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus vaccine 2009 |
Unknown Cell Type 2 |
influenza virus vaccine 2009 injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2009 injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2009 injection, 1 x 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2009 injection, 1 x 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2009 injection, 10 x 0.25 mL syringes |
Unknown Cell Type 2 |
influenza virus vaccine 2009 injection, 10 x 0.5 mL syringes |
Unknown Cell Type 2 |
influenza virus vaccine 2010 |
Unknown Cell Type 2 |
influenza virus vaccine 2010 injection, 0.1 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2010 injection, 0.25 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2010 injection, 0.5 mL syringe |
Unknown Cell Type 2 |
influenza virus vaccine 2010 injection, 1 x 0.1 mL syringe |
Unknown Cell Type 2 |